PharmaTimes - April 2018

It’s all about digital in this issue of PharmaTimes.

In our cover feature (p29) we’ll be taking a look at all the ways digital tech will be changing the industry in years to come. We also have features taking a deeper look at how sensor technology is being embedded in pills to measure adherence (p26) and how AI is being used to tackle non-alcoholic fatty liver disease (p33).

You can also look forward to a big focus on AI in our next issue, where we’ll be looking at how it’s impacting every aspect of pharma.

Elsewhere we take a look at several important IP cases that might change the industry (p22), shake-ups in medical device regulation (p20) and how biotech Probiodrug is hoping to take on the notoriously difficult disease area of Alzheimer’s (p36).

Don’t forget that tickets are now on sale for our International Clinical Researcher of the Year Competition – and on p38 we reveal the finalists who will be competing for these prestigious awards.

I hope you enjoy the issue.

April 2018 - magazine highlights

SmartPeople: Mark Samuels

The industry veteran talks about how he’s helping to chang...

Patient Files: Niemann-Pick type C

After having two of their children diagnosed with NP-C, Ph...

Living in interesting times

For investors the future is bright, but it isn’t pharma

Patent pending

A look at some of the most important pharma IP cases from...

A new landscape for medical devices

Pharma businesses need to prepare now for the EU’s sweepin...

The new power brokers

How pharma should adapt to changes in the NHS that are imp...

Company focus: Perspectum Diagnostics

How this Oxford spinout is using AI to tackle challenges i...

Digital sensor medicines: the holy grail in adherence?

Will drugs that track adherence when ingested be a tough p...

Taking Alzheimer’s head-on

German biotech Probiodrug is hoping its lead candidate can...

iPharma

What's next for digital in pharma?